1. Home
  2. AZUL vs NNNN Comparison

AZUL vs NNNN Comparison

Compare AZUL & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZUL
  • NNNN
  • Stock Information
  • Founded
  • AZUL 2008
  • NNNN 2021
  • Country
  • AZUL Brazil
  • NNNN Germany
  • Employees
  • AZUL N/A
  • NNNN N/A
  • Industry
  • AZUL Air Freight/Delivery Services
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AZUL Consumer Discretionary
  • NNNN Health Care
  • Exchange
  • AZUL Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • AZUL 271.1M
  • NNNN 267.7M
  • IPO Year
  • AZUL 2017
  • NNNN 2025
  • Fundamental
  • Price
  • AZUL $0.66
  • NNNN $6.43
  • Analyst Decision
  • AZUL Hold
  • NNNN
  • Analyst Count
  • AZUL 8
  • NNNN 0
  • Target Price
  • AZUL $4.67
  • NNNN N/A
  • AVG Volume (30 Days)
  • AZUL 12.7M
  • NNNN 28.8K
  • Earning Date
  • AZUL 05-20-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • AZUL N/A
  • NNNN N/A
  • EPS Growth
  • AZUL N/A
  • NNNN N/A
  • EPS
  • AZUL N/A
  • NNNN 0.06
  • Revenue
  • AZUL $3,157,077,406.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • AZUL N/A
  • NNNN N/A
  • Revenue Next Year
  • AZUL $8.77
  • NNNN N/A
  • P/E Ratio
  • AZUL N/A
  • NNNN $118.17
  • Revenue Growth
  • AZUL 5.24
  • NNNN 21.95
  • 52 Week Low
  • AZUL $0.48
  • NNNN $5.18
  • 52 Week High
  • AZUL $6.64
  • NNNN $7.82
  • Technical
  • Relative Strength Index (RSI)
  • AZUL 23.00
  • NNNN N/A
  • Support Level
  • AZUL $0.65
  • NNNN N/A
  • Resistance Level
  • AZUL $0.79
  • NNNN N/A
  • Average True Range (ATR)
  • AZUL 0.17
  • NNNN 0.00
  • MACD
  • AZUL -0.02
  • NNNN 0.00
  • Stochastic Oscillator
  • AZUL 15.13
  • NNNN 0.00

About AZUL Azul S.A. (each representing three preferred shares)

Azul SA is involved in the operation of regular and non-regular airline passenger services, cargo or mail, passenger charter, provision of maintenance and hangarage services for aircraft, engines, parts and pieces, aircraft acquisition and lease, development of frequent-flyer programs, development of related activities and equity holding in other companies. The Company considers that it has a single reportable segment which is air transport.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: